Alimera Sciences (ALIM)
Create an Alert
5.39
-0.01 -0.19%
NASDAQ
Jun 18, 8:00PM
BATS Real time
Currency in USD
Alimera Sciences Long Term Debt:
2.976M for Dec. 31, 2012Alimera Sciences Historical Long Term Debt Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 2.976M |
| Sept. 30, 2012 | 3.712M |
| June 30, 2012 | 4.141M |
| March 31, 2012 | 4.794M |
| Dec. 31, 2011 | 5.33M |
| Sept. 30, 2011 | 5.887M |
| June 30, 2011 | 6.083M |
| March 31, 2011 | 6.014M |
| Dec. 31, 2010 | 5.924M |
| Sept. 30, 2010 | 0.00 |
| June 30, 2010 | 0.00 |
| March 31, 2010 | 15.00M |
| Dec. 31, 2009 | 15.00M |
| Sept. 30, 2009 | 15.00M |
| June 30, 2009 | |
| March 31, 2009 | |
| Dec. 31, 2008 | 15.00M |
| Sept. 30, 2008 | |
| June 30, 2008 | 0.004M |
| March 31, 2008 | Go Pro |
About Long Term Debt
Long-term debts are financial obligations and loans lasting longer than one year. A company must report long-term debt on its balance sheet with its date of maturity and interest rate.
Bonds and debt obligations with maturities greater than one year are examples of long-term debt. Other types of securities, including short-term notes and commercial papers usually are not long-term debt because their maturities typically are shorter than one year.
IMPORTANT: YCharts includes the Current Portion of Long Term Debt in our calculation of Long Term Debt.
Learn More
ALIM Long Term Debt Benchmarks
| Companies | |
|---|---|
| pSivida | 0.00 |
| Ampio Pharmaceuticals | 0.00 |
| Echo Therapeutics | 0.00 |
ALIM Long Term Debt Rankings
| Overall |
74th percentile 4221 of 16770 |
| Sector |
59th percentile 568 of 1408 in Healthcare |
| Industry |
65th percentile 46 of 135 in Drug Manufacturers - Major |
ALIM Long Term Debt Range, Past 5 Years
| Minimum | 0.000 | Jun 2010 |
| Maximum | 15.00M | Dec 2008 |
| Average | 6.554M |
ALIM News
Alimera Sciences (ALIM) Receives Positive ACD from NICE on ILUVIEN as DME Treatment
Street Insider Jun 14
Street Insider Jun 14
